The cases of death occurred after administration of the AstraZeneca vaccine only have a temporal link. No causality was demonstrated between the two events. The alarm on safety of the AstraZeneca vaccine is not justified.

AIFA underlines that pharmacovigilance activities continue both at national and European level in collaboration with EMA, by carefully monitoring any possible adverse effect related to vaccination.

AIFA strongly reassures citizens on safety of the AstraZeneca vaccine, with a view to optimal adherence to the ongoing vaccination campaign.